PKO Investment Management Joint Stock Co Reduces Stake in UnitedHealth Group Incorporated $UNH

PKO Investment Management Joint Stock Co cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 10.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,789 shares of the healthcare conglomerate’s stock after selling 1,600 shares during the period. PKO Investment Management Joint Stock Co’s holdings in UnitedHealth Group were worth $3,731,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. High Net Worth Advisory Group LLC increased its position in UnitedHealth Group by 42.2% during the first quarter. High Net Worth Advisory Group LLC now owns 1,745 shares of the healthcare conglomerate’s stock valued at $472,000 after acquiring an additional 518 shares during the last quarter. XML Financial LLC boosted its stake in shares of UnitedHealth Group by 8.8% during the 1st quarter. XML Financial LLC now owns 1,388 shares of the healthcare conglomerate’s stock worth $376,000 after purchasing an additional 112 shares during the period. Clark Asset Management LLC raised its position in UnitedHealth Group by 4.7% in the 1st quarter. Clark Asset Management LLC now owns 908 shares of the healthcare conglomerate’s stock worth $246,000 after purchasing an additional 41 shares during the period. FARMERS & MERCHANTS TRUST Co OF LONG BEACH boosted its position in shares of UnitedHealth Group by 0.5% during the first quarter. FARMERS & MERCHANTS TRUST Co OF LONG BEACH now owns 15,960 shares of the healthcare conglomerate’s stock valued at $4,319,000 after buying an additional 84 shares during the period. Finally, CPC Advisors LLC raised its holdings in shares of UnitedHealth Group by 93.1% in the first quarter. CPC Advisors LLC now owns 1,674 shares of the healthcare conglomerate’s stock worth $453,000 after buying an additional 807 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.4%

NYSE:UNH opened at $406.60 on Tuesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The firm has a market cap of $369.25 billion, a PE ratio of 30.71, a price-to-earnings-growth ratio of 1.61 and a beta of 0.64. The company has a 50-day moving average of $375.68 and a 200 day moving average of $330.17. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $415.98.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company’s revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 18.32 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th will be issued a $2.32 dividend. The ex-dividend date is Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio (DPR) is 70.09%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on UNH shares. Raymond James Financial upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective for the company in a report on Wednesday, April 1st. Robert W. Baird boosted their target price on shares of UnitedHealth Group from $278.00 to $287.00 and gave the company an “underperform” rating in a research note on Wednesday, April 22nd. Barclays lifted their price objective on shares of UnitedHealth Group from $373.00 to $429.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. Sanford C. Bernstein upped their target price on shares of UnitedHealth Group from $444.00 to $492.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 27th. Finally, Leerink Partners boosted their price target on UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a report on Wednesday, June 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $409.75.

Read Our Latest Stock Analysis on UnitedHealth Group

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.